resource-symbol

Diabetes Medication Satisfaction (DiabMedSat)

Novo Nordisk (Denmark)

Distributed by Mapi Research Trust

Distributed by Mapi Research Trust

default distrib
 

Basic description

Authors

Novo Nordisk (Denmark)

Meryl Brod, Soren E Skovlund, Kim Wittrup-Jensen (initial development and validation study)
Copyright
DiabMedSat © Novo Nordisk, 2004. All rights reserved
Objective
To measure diabetes treatment satisfaction, applicable to a wide range of diabetes therapies
Therapeutic area
  • Nutritional and Metabolic Diseases
  • Endocrine System Diseases
Therapeutic indication

Diabetes Mellitus

Type 1 – IDDM, Type 2 – NIDDM, Type 2 – Insulin requiring patients
Type of Clinical Outcome Assessment (COA)
  • PRO PRO
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire

Brod M, Skovlund SE, Wittrup-Jensen KU. Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Qual Life Res. 2006 Apr;15(3):481-91 (PubMed Abstract)


Contact and conditions of use

Authors

Novo Nordisk (Denmark)

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Non-Commercial Users

If you do not receive specific funding for your study, you may download the questionnaire directly:

  1. Log in or Register for free
  2. Click the 'Online distribution' tab in the left menu bar and follow the instructions

Tutorials are available on our FAQs.

Commercial Users

All requests have to be submitted through our online request management:

  1. Log in or Register for free
  2. Submit your request (Tutorials are available on our FAQs)
  3. In order to accelerate the process, you may attach the User Agreement (even if not finalized) to your online request. Click the link below for the user agreement template.
  4. Our PROVIDE team will get back to you with the needed information in a timely manner

Access fees

ROYALTY FEES* Commercial users Cost per study 1 100 €
Cost per language 550 €
Funded academic research Cost per study Free
Cost per language Free
Not funded academic users Cost per study Free
Cost per language Free
DISTRIBUTION FEES* Commercial users Cost per study 1 000 €
Cost per language 500 €
Funded academic research Cost per study 300 €
Cost per language 50 €
Not funded academic users Cost per study Free
Cost per language Free

* Excluding VAT
Commercial users: Industry, CRO, any for-profit companies
Funded Academic research: Projects receiving funding from commerce, government, EU or registered charity. Funded academic research– sponsored by industry fits the “commercial users” category.
Not funded academic users, individual medical practice: Projects are not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Online distribution

For Non-Funded Academic Studies

The following licensing process is restricted to academic users:

  • Who do not receive specific funding for their study
  • Who intend to use the questionnaire in individual clinical practice or research study

Should you not correspond to this category of users, please send us a request.

Note: This site aims at providing you with the original version and existing translations of the questionnaire. However some modules/versions may not be downloadable in the language you need.

Login

To access this section, please complete a client account.

Languages

Original language(s)

  • English for the USA

Translations

The translations listed may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

DiabMedSat

Afrikaans for South Africa*
Arabic for Israel
Cebuano for the Philippines
Chinese for Hong Kong
Chinese for Singapore
Chinese for Taiwan
Croatian for Croatia
Danish for Denmark
Dutch for the Netherlands
English for Australia
English for Canada
English for India*
English for South Africa*
English for the Philippines*
English for the UK
Finnish for Finland
French for Canada
French for France
German for Austria
German for Germany
German for Switzerland
Hebrew for Israel
Hindi for India
Hungarian for Hungary*
Italian for Italy
Japanese for Japan
Kannada for India
Korean for Korea*
Macedonian for Macedonia
Malay for Singapore
Mandarin for China
Marathi for India
Norwegian for Norway*
Polish for Poland
Portuguese for Brazil
Russian for Israel
Spanish for Colombia*
Spanish for Mexico
Spanish for Peru*
Spanish for Spain
Spanish for the USA
Swedish for Finland
Swedish for Sweden
Tagalog for the Philippines
Tamil for India
Telugu for India
Turkish for Turkey
* Performed by Mapi

The author has selected Mapi as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi

Last update: February 2017
For additional information, please submit a request. More information in our FAQs.